Remove Capital Investments Remove Mergers and Acquisitions Remove Prospects
article thumbnail

500 Million Reasons to Buy This Cathie Wood SpaceX Competitor in 2024

The Motley Fool

Rocket Lab's return from orbit Like fellow commercial space businesses Virgin Galactic and Astra Space , Rocket Lab went public through a special purpose acquisition company ( SPAC ). The space industry requires a significant level of capital investment. According to a recent regulatory filing, on Dec.

article thumbnail

Scaling an RIA Through Strategic Acquisitions and Organic Growth with Gary Roth and Mike Capelle of Modern Wealth Management

Steve Sanduski

We dive into their approach to scaling through acquisitions, the importance of organic growth, and how they’re investing in their team to create a company culture that prioritizes innovation, client success, and career development. The strategies and expectations that come with private equity investments.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

EOG Resources (EOG) Q3 2024 Earnings Call Transcript

The Motley Fool

I'd love to hear your latest thoughts on how you're thinking about the prospectivity more on the west side of the play, either in that black oil or volatile oil in the play? On the prospectivity overall, you know, we are still focused mainly on the volatile oil window and trying to, you know, dial down spacing there. Please go ahead.

Debt 130
article thumbnail

2024 Valuation Expectations: Insights From Axial Investment Bankers

Axial

Prospective buyers have cash and ample liquidity. Brian Egwele Egwele & Company Interest rates, available capital, consolidation. Shep Campbell Merger & Acquisition Specialists Interest Rates, Uncertainty, normalization of EBITDA as we continue to pull away from the Covid era. Credit markets are improving.

article thumbnail

Globus Medical (GMED) Q1 2024 Earnings Call Transcript

The Motley Fool

Non-GAAP EPS was $0.72, increasing 36% versus prior year, even with the 32% increase in outstanding shares driven by the merger. The combination of these two businesses is one of the strengths of our merger, offering a broad range of product and market-changing innovation. Operations remains the strength of the merger.

article thumbnail

Globus Medical (GMED) Q2 2024 Earnings Call Transcript

The Motley Fool

Globus delivered another robust post-merger quarter in Q2 with sales of $630 million, growing 116% or $338 million. Non-GAAP EPS was $0.75, increasing 20% versus prior year even with the 35% increase in outstanding shares driven by the merger. I believe our long-term prospect as a leading innovator have never been stronger.

article thumbnail

Stratasys (SSYS) Q2 2023 Earnings Call Transcript

The Motley Fool

Please also refer to our operating and financial review and prospects for 2022 and for the second quarter of 2023, which were included as Item 5 of our annual report on Form 20-F for 2022 and in Exhibit 99.2 We expect to introduce new materials resulting from the acquisition later this year. We generate a recurring revenue stream.